You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨AI醫療概念股方舟健客逆勢大升超11%
格隆匯 06-17 10:30
AI醫療概念股、國內最大在線慢病管理平台方舟健客(6086.HK)今日盤中逆勢走強,一度升11.4%報4.3港元。消息面上,北京市近日印發《北京市支持創新醫藥高質量發展若干措施(2025年)》的通知,其中提出,鼓勵企業在京設立人工智能研發中心,加強數據需求對接,開展人工智能賦能新靶點發現、新機制探索、化合物篩選、病例隨訪等研究。建設醫療健康行業大模型測評體系,面向AI+病理、AI+醫學影像、AI+輔助診斷、AI+手術規劃、AI+製藥等方向,支持不少於10個場景的模型開發應用。推進人工智能技術應用,完善監管評價措施,促進人工智能+醫療健康融合創新規範發展。開展互聯網診療首診試點。方舟健客自成立以來,始終將科技創新放在首要位置。隨着近年來AI大模型技術的不斷進步,方舟健客緊跟技術迭代步伐,不斷強化技術底座,自主研發了“方舟健客H2H智慧醫療新生態創新平台”,為患者帶來從醫院到家庭的無縫醫療服務體驗。在技術創新方面不斷實現突破,方舟健客持續引領行業發展。2025年,方舟健客相繼接入了DeepSeek-V3、DeepSeek-R1滿血模型等大模型,並完成私有化部署。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account